首页 | 本学科首页   官方微博 | 高级检索  
     


Favorable outcome with allogeneic hematopoietic stem cell transplantation in pediatric acquired aplastic anemia patients
Authors:Unal Sule  Cetin Mualla  Tavil Betül  Calişkan Neslihan  Yetgin Sevgi  Uçkan Duygu
Affiliation:Department of Pediatrics, Division of Pediatric Hematology, Hacettepe University Faculty of Medicine, Sihhiye, Ankara, Turkey. suleunal2003@hotmail.com
Abstract:The data of allogeneic HSCT in nine children with acquired AA between June 1998 and July 2006 were analyzed retrospectively. The median duration of time to neutrophil and platelet engraftment was 18 and 25 days, respectively. None of the patients had primary graft failure. Two (22.2%) patients developed acute GVHD and of these, one (11.1%) was Grade 1, and the other (11.1%) was Grade 3. Although the study group was composed of higher risk patients, including six of nine resistant to previous immunosuppressive treatment, eight had multiple not irradiated or filtered transfusion histories and one of the cases was only 5/6 HLA-compatible with his donor, the five-yr overall and EFS was 100%, and all recipients are alive without any graft failure. This may be attributed to the dose adjusted use of ATG according to individual transfusion history and gradual tapering of CsA and cessation at least nine months after allogeneic HSCT.
Keywords:aplastic anemia    stem cell transplantation    pediatric    graft-vs.-host disease
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号